XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Common Stock
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Common Stock Common Stock
The Company’s common stockholders are entitled to dividends if and when declared by the Company’s Board of Directors, or the Board of Directors. As of March 31, 2024, and December 31, 2023, no dividends on the Company's common stock had been declared by the Board of Directors.
The Company’s common stock has been reserved for the following potential future issuances:
March 31, 2024December 31, 2023
(unaudited)
Shares underlying outstanding stock options
4,159,6784,012,903
Shares underlying unvested restricted stock units
5,236,7514,346,785
Shares underlying unvested market-based restricted stock units2,260,764
Shares underlying unvested performance-based restricted stock units1,329,525412,490
Shares available for issuance under the 2018 Incentive Award Plan11,268,4887,053,406
Shares available for issuance under the 2018 Employee Stock Purchase Plan2,786,3351,679,635
Shares available for issuance under the 2023 Employment Inducement Incentive Award Plan
4,573,4584,949,988
Total29,354,23524,715,971
Equity Offering
In May 2023, the Company completed a follow-on underwritten public offering, in which it issued and sold 14,375,000 shares of its common stock at a price of $28.00 per share, and received net proceeds of $381.4 million after deducting underwriting discounts and commissions and other offering costs of $21.1 million. In December 2023, the Company completed a registered direct offering with an investment management firm, in which it issued and sold 3,387,446 shares of its common stock at a price of $26.77 per share, and received net proceeds of $90.6 million.